Delivery Order SPE2DB22D3501-SPE2DB26FTK65
- Not listed
- The Defense Logistics Agency awarded a $3,457.77 firm fixed price delivery order to AmerisourceBergen Drug Corp for Dexamethasone 10 mg/mL vials, with an ultimate completion date of September 30, 2025. This non-set-aside award was made on September 29, 2025, and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the federal government, specifically...
- The Defense Logistics Agency awarded a $3,267.86 firm fixed price delivery order to AmerisourceBergen Drug Corp for Dexamethasone 10 mg/mL vials, with an ultimate completion date of October 27, 2025. This non-set-aside contract was competitively awarded on October 24, 2025, with performance to be executed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 5, 2025, for the supply of Dexamethasone 120 mg/30 mL vials. This competitive, non-set-aside contract is structured as a firm fixed-price delivery order with a ceiling value of $2,700.82 and an ultimate completion date of June 6, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a $1,488.18 delivery order to AmerisourceBergen Drug Corp on June 27, 2025, for the supply of Dexamethasone 20 mg/5 ml vials. This competitively awarded, firm fixed-price contract is set to be completed by June 30, 2025, with performance taking place at the company's corporate office in Conshohocken, Pennsylvania. The order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Dexamethasone 20 mg/5 ml vials in 5 ml quantities, with a ceiling value of $1,046.46. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 9, 2025. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 30, 2025, for the supply of Dexamethasone 20 mg/5 ml vials with a ceiling value of $1,066.93. This is a firm fixed-price delivery order with an ultimate completion date of October 31, 2025, and represents a non-competitive set-aside award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. This delivery order is issued...
- The Defense Logistics Agency awarded a $2,466.91 delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Dexamethasone 20 mg/5 mL vials. This firm fixed-price, competitively awarded contract—with no set-aside designation—is scheduled for completion by September 15, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Dexamethasone is a corticosteroid medication commonly used in military and federal healthcare...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of Dexamethasone 20 mg/5 mL vials with a ceiling value of $1,058.01. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The contract will be performed in Conshohocken, Pennsylvania, with an ultimate completion date of November 4, 2025. This delivery order is issued under AmerisourceBergen Drug Corp's broader...
- The Defense Logistics Agency has awarded AmerisourceBergen Drug Corp a delivery order valued at $2,945.52 for Dexamethasone 20 mg/5 mL vials (5 mL quantity) on a firm fixed price basis. This award, issued on July 17, 2025, represents a non-competitive delivery against AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion vehicle running through December 2026 that serves as the primary pharmaceutical supply mechanism for U.S. military...
- The Defense Logistics Agency awarded a delivery order valued at $16,659.62 to AmerisourceBergen Drug Corp for the supply of Dexamethasone 0.5 mg/5 mL elixir in a 237 mL quantity. This firm fixed-price delivery order, issued on November 7, 2025, with an ultimate completion date of November 10, 2025, was competitively awarded without set-aside restrictions. The order is being fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company serves as a...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB26FTK65Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,897.24 to AmerisourceBergen Drug Corp for Dexamethasone 10 mg/mL vials on November 6, 2025. This firm fixed-price contract, with a completion date of November 7, 2025, represents a non-set-aside, competitively awarded transaction for pharmaceutical supply supporting federal medical procurement needs. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply medications, vaccines, and medical supplies to military healthcare systems and other federal agencies including the Defense Health Agency and U.S. Coast Guard. The company's role as a major pharmaceutical distributor and established federal vendor demonstrates its capability to meet DLA's medical supply chain requirements across multiple therapeutic domains through open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 11/6/25 |